SION · Sionna Therapeutics, Inc.

$45.66 -0.90 (-1.92%)

Market Cap

$2.10B

45.15M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Cloonan	CEO	$646,580	—	—	$5,950,575	$374,062	$10,000	$6,981,217
Caroline Stark Beer	Chief Business Officer	$158,945	$30,000	—	$5,324,783	$71,599	$7,569	$5,592,896
Elena Ridloff	CFO	$506,677	—	—	$2,085,765	$254,925	$10,000	$2,857,367

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Cloonan	CEO	$506,189	—	—	$2,942,192	$278,404	—	$3,726,785
Elena Ridloff	CFO	$449,946	—	—	$652,725	$197,976	—	$1,300,647
Charlotte McKee	Chief Medical Officer	$449,946	—	—	$635,318	$197,976	—	$1,283,240
Caroline Stark Beer	Chief Business Officer	—	—	—	—	—	—	—

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Cloonan	CEO	$486,720	—	—	—	$267,696	—	$754,416
Charlotte McKee	Chief Medical Officer	$432,640	—	—	—	$190,362	—	$623,002
Elena Ridloff	CFO	$432,640	—	—	—	$190,362	—	$623,002

Key facts CIK 2036042 CUSIP 829401108 13F (30d) 13 filings 13 filers Visit website Investor relations